3 Stocks To Benefit From A US Rate Hike: AstraZeneca plc, BHP Billiton plc And Unilever plc

AstraZeneca plc (LON:AZN), BHP Billiton plc (LON:BLT) and Unilever plc (LON:ULVR) can all benefit…

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Next month could deliver a shock to the system if the US Federal Reserve really does hike interest rates for the first time in nearly a decade.

The last time the Fed actually lifted rates was in June 2006, so for many newbie investors this will be unknown territory. It may knock markets off course (as it did last time) but there will be some positives for UK investors. High interest rates mean a stronger dollar, especially if the Fed hikes rates twice this year, as many expect.

This is good news for Britain’s with shares in FTSE 100 companies that pay their dividends in dollars, whose income will look even more attractive when converted into relatively weak sterling. The last 12 months have already been good news for dollar dividends, with the pound falling to $1.55 today, against $1.66 one year ago, a drop of 6.6%. Now there could be more to come.

Here are three companies that should benefit.

AstraZeneca

Pharmaceutical giant AstraZeneca (LSE: AZN) currently yields 4.20% and the money hits your bank account in dollars, which means it could look even juicier next month.

The stock has had a tough time lately, however, falling 6.8% in the last six months, worse than the 5% drop in the FTSE 100. Q2 core operating profits fell 4% to £3.62 bn, as management focuses on investing heavily in its drugs pipeline. Things could get tougher with treatments Crestor and Nexium both coming off patent in the next couple of years, as they accounted for a third of group sales last year.

AZN’s future will largely depend on whether chief executive Pascal Soriot is right to put his faith in the company’s new generation of blockbuster cancer drugs, which he hopes will deliver $45bn-plus revenues by 2023. But it is nice to see a FTSE 100 company investing hard for the future, given so much short-termism elsewhere. And you get a dollar-driven dividend while you wait.

BHP Billiton

Investors in troubled mining giant BHP Billiton (LSE: BLT) need some good news, with the stock down almost 40% in the last year on falling demand from China. Personally, I think China will get worse before things get better, although there are signs that the authorities’ latest stimulus this package will keep the growth story rattling along for a few years more.

What is bad news for BHP Billiton’s share price is good news for income investors, with the stock now yielding 6.39%. A stronger dollar would give a further real-terms boost to UK investors.

BHP Billiton is now dividend dynamite, although unless they are reversed, falling metals prices (iron ore now trades at $56 a tonne against $140 in January last year) must eventually force management to cut the payout. The board remains committed to the dividend from now, but expect rumblings ahead.

Unilever

Household goods giant Unilever (LSE: ULVR) is much admired by investors but its success has a downside: it has historically traded at more than 20 times earnings and yields as low as 2.5%.

Recent share price slippage has improved both figures, with the price/earnings ratio at a relatively (for Unilever) affordable 17 times, and the yield at 3.22%. A dollar surge could make that yield a little more rewarding.

Many investors backed Unilever as a safe way to play China and emerging markets, and sales from this source are still growing at around 6.5%, although the days of double-digit growth are over. Worryingly, European sales are falling.

But Unilever has delivered the goods from more than 20 years and at today’s price long-term investors should still clean up.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK owns shares of Unilever. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£9k of savings? Here’s how an investor could aim to turn it into a second income of £560 a month

Christopher Ruane digs into the theory and numbers of how an investor could target a chunky monthly second income of…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

A top S&P 500 value share to consider as markets sell off!

Worried about the outlook for S&P 500 shares in the New Year? Buying value stocks like this tech giant is…

Read more »

Investing Articles

£20k of savings? Here’s how an investor could target £980 of passive income each month

With a £20k pot to deploy, our writer outlines how a long-term investor could target almost £1k a month in…

Read more »

Investing Articles

FTSE shares: a bargain way to start building wealth in 2025?

Christopher Ruane explains how, by buying FTSE 100 shares at what he thinks are bargain prices, he hopes to build…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

3 ISA mistakes to avoid in 2025

Our writer outlines a trio of mistakes investors can make in their ISA, to their cost, and explains why he’s…

Read more »

Older couple walking in park
Investing Articles

3 UK shares to consider as a long-term investment for retirement

Our writer identifies three UK shares with long-term growth potential he believes investors should think about holding until retirement and…

Read more »

Pink 3D image of the numbers '2025' growing in size
Investing Articles

Could this beaten-down FTSE 250 stock be on the cusp of a recovery in 2025?

After this FTSE 250 financial services stock lost another 24% of its value in 2024, Andrew Mackie sees the potential…

Read more »

The Milky Way at night, over Porthgwarra beach in Cornwall
Investing Articles

Warren Buffett says make passive income while sleeping! Here’s my plan to do so

Billionaire Warren Buffett has said many wise things over the past half a century, including a thing or two about…

Read more »